Outcomes inN3Head and Neck Squamous Cell Carcinoma and Role of Upfront Neck Dissection

被引：7

作者：

Boros, Angela ^{[1
]}

Blanchard, Pierre ^{[1
,2
]}

Dade, Arlette ^{[3
]}

Gorphe, Philippe ^{[3
]}

Breuskin, Ingrid ^{[3
]}

Even, Caroline ^{[3
]}

Nguyen, France ^{[1
]}

Deutsch, Eric ^{[1
,2
,4
]}

Bidault, Francois ^{[5
]}

Janot, Francois ^{[3
]}

Temam, Stephane ^{[3
]}

Mirghani, Haitham ^{[3
]}

Tao, Yungan ^{[1
,2
,4
]}

机构：

[1] Gustave Roussy Canc Campus, Dept Radiat Oncol, 114 Rue Edouard Vaillant, F-94805 Villejuif, France

[2] Univ Paris Sud, Le Kremlin Bicetre, France

[3] Gustave Roussy Canc Campus, Dept Head & Neck Oncol, Villejuif, France

[4] INSERM 1030 Mol Radiotherapy, Villejuif, France

[5] Gustave Roussy Canc Campus, Dept Radiol, Villejuif, France

来源：

LARYNGOSCOPE | 2021年 / 131卷 / 03期

关键词：

Head and neck cancer; N3; neck dissection; chemoradiotherapy; CONCOMITANT CHEMOTHERAPY; ADVANCED HEAD; CANCER; RADIOTHERAPY; CHEMORADIOTHERAPY; N3;

D O I：

10.1002/lary.28893

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Objectives We investigated the prognostic factor of N3 head and neck squamous cell carcinoma (HNSCC), including the role of upfront neck dissection (UFND) before radiotherapy (RT). Methods We retrospectively reviewed the charts of consecutive N3 HNSCC patients treated with curative intent RT. Results In the study, 323 N3 HNSCC patients were included. Of those, 125 patients (39%) had UFND. Median follow-up was 3.9 years (0-14.8 years). Overall survival (OS) at 5 years was 31.2%, and progression-free survival (PFS) was 26%. In the multivariate analysis, OS was improved in PS 0, T1-2 tumors, patients receiving concurrent chemotherapy, never or former smokers, and UFND. UFND was strongly associated with increased OS (45.7% vs. 21.2%,P < .001), and PFS (P < .001). Regardless of neck node size, UFND improved survival (P= .001 for <= 7 cm andP= .004 for > 7 cm). Conclusion UFND could improve treatment outcomes in N3 HNSCC, especially for non-oropharyngeal cancer, regardless of neck node size. Level of Evidence 2BLaryngoscope, 2020

引用

页码：E844 / E850

页数：7

共 50 条

[31] CURRENT STATUS OF NECK DISSECTION IN THE MANAGEMENT OF SQUAMOUS CARCINOMA OF THE HEAD AND NECK
OBRIEN, CJ
URIST, MM
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1987, 57 (08): : 501 - 509
[32] OUTCOME WITH NECK DISSECTION AFTER CHEMORADIATION FOR N3 HEAD-AND-NECK SQUAMOUS CELL CARCINOMA
Igidbashian, Levon
Fortin, Bernard
Guertin, Louis
Soulieres, Denis
Coulombe, Genevieve
Belair, Manon
Charpentier, Danielle
Tabet, Jean-Claude
Nguyen-Tan, Phuc Felix
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02): : 414 - 420
[33] SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK TREATED WITH RADIATION-THERAPY - THE ROLE OF NECK DISSECTION FOR CLINICALLY POSITIVE NECK NODES
MENDENHALL, WM
MILLION, RR
CASSISI, NJ
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (05): : 733 - 740
[34] Squamous Cell Cancer of an Unknown Primary Head and Neck Site: Is Upfront Neck Dissection Still Relevant in the Era of Chemoradiation?
Amsbaugh, M. J.
Perez, C. A.
Gaskins, J.
Silverman, C. L.
Bumpous, J.
Potts, K.
Rajeurs, A. A.
Redman, R.
Dunlap, N. E.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 894 - 894
[35] Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy
Demiroz, Candan
Vainshtein, Jeffrey M.
Koukourakis, Georgios V.
Gutfeld, Orit
Prince, Mark E.
Bradford, Carol R.
Wolf, Gregory T.
McLean, Scott
Worden, Francis P.
Chepeha, Douglas B.
Schipper, Matthew J.
McHugh, Jonathan B.
Eisbruch, Avraham
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (11): : 1589 - 1595
[36] Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma
Amit, Moran
Liu, Chuan
Mansour, Jobran
Gleber-Netto, Frederico O.
Tam, Samantha
Baruch, Erez N.
Aashiq, Mohamed
El-Naggar, Adel K.
Moreno, Amy C.
Rosenthal, David I.
Glisson, Bonnie S.
Ferrarotto, Renata
Wong, Michael K.
Tsai, Kenneth
Flores, Elsa R.
Migden, Michael R.
Silverman, Deborah A.
Li, Goujun
Khanna, Anshu
Goepfert, Ryan P.
Nagarajan, Priyadharsini
Weber, Randal S.
Myers, Jeffrey N.
Gross, Neil D.
CANCER, 2021, 127 (23) : 4413 - 4420
[37] Is elective neck dissection indicated during salvage surgery for head and neck squamous cell carcinoma?
Alvaro Sanabria
Carl E. Silver
Kerry D. Olsen
Jesus E. Medina
Marc Hamoir
Vinidh Paleri
Vanni Mondin
Alessandra Rinaldo
Juan P. Rodrigo
Carlos Suárez
Carsten C. Boedeker
Michael L. Hinni
Luiz P. Kowalski
Afshin Teymoortash
Jochen A. Werner
Robert P. Takes
Alfio Ferlito
European Archives of Oto-Rhino-Laryngology, 2014, 271 : 3111 - 3119
[38] Is elective neck dissection indicated during salvage surgery for head and neck squamous cell carcinoma?
Sanabria, Alvaro
Silver, Carl E.
Olsen, Kerry D.
Medina, Jesus E.
Hamoir, Marc
Paleri, Vinidh
Mondin, Vanni
Rinaldo, Alessandra
Rodrigo, Juan P.
Suarez, Carlos
Boedeker, Carsten C.
Hinni, Michael L.
Kowalski, Luiz P.
Teymoortash, Afshin
Werner, Jochen A.
Takes, Robert P.
Ferlito, Alfio
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (12) : 3111 - 3119
[39] Elective Neck Dissection for Head and Neck Cutaneous Squamous Cell Carcinoma with Skull Base Invasion
Cannon, Richard B.
Dundar, Yusuf
Thomas, Andrew
Monroe, Marcus M.
Buchmann, Luke O.
Witt, Benjamin L.
Sowder, Aleksandra M.
Hunt, Jason P.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 156 (04) : 671 - 676
[40] Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
Dean, Nichole R.
Sweeny, Larissa
Magnuson, J. Scott
Carroll, William R.
Robinson, Daniel
Desmond, Renee A.
Rosenthal, Eben L.
JOURNAL OF SKIN CANCER, 2011, 2011

← 1 2 3 4 5 →